Dipexium Pharmaceuticals Inc (NASDAQ:DPRX)
| 11.82 Data as of 11:36am ET |  +0.32 / +2.78%Today’s Change | 8.00 Today|||52-Week Range 15.86 | +3.82% Year-to-Date |
Latest DPRX News | Press Releases
No recent news for Dipexium Pharmaceuticals Inc.
Today’s Trading
| Previous close | 11.50 |
| Today’s open | 11.77 |
| Day’s range | 11.00 - 11.82 |
| Volume | 21,440 |
| Average volume (3 months) | 25,921 |
| Market cap | $98.2M |
| Dividend yield | -- |
Data as of 11:36am ET, 01/26/2015
Growth & Valuation
| Earnings growth (last year) | -93.33% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +40.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2,956.30 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --United Gene High-Tec... | +0.00 | +1.35% |
| CPXXCelator Pharmaceutic... | +0.06 | +2.11% |
| NERVMinerva Neuroscience... | -0.08 | -1.55% |
| SCYXSCYNEXIS Inc | -0.19 | -1.58% |
Data as of 11:54am ET, 01/26/2015
Financials
| Next reporting date | February 25, 2015 |
| EPS forecast (this quarter) | -$0.52 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$4.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, CEO, Secretary & Director David P. Luci |
Vice President-Finance & Corporate Development David Garrett |
Corporate headquarters New York, New York |
Forecasts
.